Autoimmune post-infantile giant cell hepatitis: a case report and review of the literature.

Canadian liver journal Pub Date : 2021-04-29 eCollection Date: 2021-01-01 DOI:10.3138/canlivj-2020-0024
Yasi Xiao, Zu-Hua Gao, Marc Deschenes
{"title":"Autoimmune post-infantile giant cell hepatitis: a case report and review of the literature.","authors":"Yasi Xiao,&nbsp;Zu-Hua Gao,&nbsp;Marc Deschenes","doi":"10.3138/canlivj-2020-0024","DOIUrl":null,"url":null,"abstract":"<p><p>Giant cell hepatitis (GCH) is a rare entity in adults that is characterized by large multinucleated hepatocyte formation and parenchymal inflammation. We present a case of acute liver failure in a 33-year-old woman secondary to autoimmune hepatitis (AIH). A liver biopsy revealed submassive hepatocyte necrosis consistent with GCH. We conducted a literature review of 187 reported cases of post-infantile GCH in adults. AIH was the most commonly reported cause of GCH, but GCH was associated with a wide spectrum of etiologies, including infections, rheumatological diseases, hematological diseases, malignancies, and medications. The severity of disease can range from mild hepatitis to fulminant hepatic failure. The mortality rate among the cases in the literature was 18.82%. GCH is managed by treating the underlying cause, and ribavirin has been proposed as a treatment option for idiopathic GCH. A small number of patients progress to requiring orthotopic liver transplant, but recurrence is possible post-transplant.</p>","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"4 2","pages":"104-109"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204937/pdf/canlivj-2020-0024.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian liver journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3138/canlivj-2020-0024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Giant cell hepatitis (GCH) is a rare entity in adults that is characterized by large multinucleated hepatocyte formation and parenchymal inflammation. We present a case of acute liver failure in a 33-year-old woman secondary to autoimmune hepatitis (AIH). A liver biopsy revealed submassive hepatocyte necrosis consistent with GCH. We conducted a literature review of 187 reported cases of post-infantile GCH in adults. AIH was the most commonly reported cause of GCH, but GCH was associated with a wide spectrum of etiologies, including infections, rheumatological diseases, hematological diseases, malignancies, and medications. The severity of disease can range from mild hepatitis to fulminant hepatic failure. The mortality rate among the cases in the literature was 18.82%. GCH is managed by treating the underlying cause, and ribavirin has been proposed as a treatment option for idiopathic GCH. A small number of patients progress to requiring orthotopic liver transplant, but recurrence is possible post-transplant.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
婴儿后自身免疫性巨细胞肝炎1例报告及文献复习
巨细胞肝炎(GCH)是一种罕见的成人疾病,其特征是大的多核肝细胞形成和实质炎症。我们提出一个病例急性肝衰竭在一个33岁的妇女继发于自身免疫性肝炎(AIH)。肝活检显示大量的肝细胞坏死与GCH相符。我们对187例报道的婴儿后成人GCH进行了文献回顾。AIH是GCH最常见的病因,但GCH与多种病因相关,包括感染、风湿病、血液病、恶性肿瘤和药物治疗。疾病的严重程度可从轻度肝炎到暴发性肝衰竭。文献中病例死亡率为18.82%。GCH是通过治疗根本原因来管理的,利巴韦林已被提议作为特发性GCH的治疗选择。少数患者进展到需要原位肝移植,但移植后可能复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Population-level cascade of care for hepatitis C in Newfoundland and Labrador Isolated hepatic sarcoidosis: A case series Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated steatotic liver disease Impact of statins in the liver: A bane or a boon?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1